Skip to main content

Table 1 Schedule for the assessments

From: Adding smartphone-based cognitive-behavior therapy to pharmacotherapy for major depression (FLATT project): study protocol for a randomized controlled trial

  

Item

Week 0

Week 1

Week 5

Week 9

Week 17

 

PRIME-MD

    
 

Basic characteristicsa

    
  

Electrocardiogram

   
  

Informed consent

    
  

BDI-II

PHQ-9

FIBSER

Blindness

  

Treatment satisfaction

   

Allocation

 

   

Participant

K6

 

 
 

(Only those allocated to Kokoro-App)

(Only those allocated to Kokoro-App)

 

(Only those allocated to Kokoro-App)

 
  1. BDI-II Beck Depression Inventory-II, CRC clinical research coordinator, FIBSER Frequency, Intensity, and Burden of Side Effects Rating, K6 6-item self-report questionnaire to evaluate the severity of general psychological distress, PHQ-9 Patient Health Questionnaire-9, PRIME-MD Primary Care Evaluation of Mental Disorders
  2. aBasic characteristics include sex, age, education, work status, marital status, age at first depressive episode, number of episodes, duration of the current depressive episode, information about treatment for current episode, and current history of physical illnesses